Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2015

01-06-2015 | Research Article

Exploring community pharmacists’ experiences of surveying patients for drug utilization research purposes

Authors: Pia Frisk, Ulrika Bergman, Sofia Kälvemark-Sporrong

Published in: International Journal of Clinical Pharmacy | Issue 3/2015

Login to get access

Abstract

Background Patient self-reported data are important in drug utilization research, but often logistically difficult to collect. During 2006–2012, 72 Swedish community pharmacies regularly collected such data through structured survey interviews at the pharmacy counter, performed by the dispensing pharmacists. This study is part of a validation of that data acquisition method. Objectives (1) To explore the experiences of the pharmacists involved, (2) to explore a random or systematic exclusion of eligible patients by the pharmacists, and (3) to find areas of improvement to the applied method of surveying. Setting 72 Swedish community pharmacies, distributed all over the country. Method (a) A questionnaire was distributed to approximately 400 dispensing pharmacists at the pharmacies conducting the patient surveys; (b) semi-structured telephone interviews conducted with 19 pharmacists at 12 of the pharmacies. Main outcome measure Proportions of pharmacists reporting positive and negative experiences of structured survey interviews, the nature of their experiences, proportion of pharmacists reporting to avoid survey interviews and reasons for doing so, and suggested areas of improvement. Results A total of 126 pharmacists (32 %) completed the questionnaire. A majority (82 %) reported positive experiences of interviewing. In addition to the data generated as the primary goal of surveying, secondary benefits such as an improved patient–pharmacist dialogue and an increased detection and resolution of drug related problems were reported. However, a majority (63 %) of the pharmacists also reported negative experiences related to a perceived lack of time to fulfil one’s professional obligations. Almost half of the pharmacists (44 %) in the survey admitted that they occasionally avoided interviewing eligible patients, due to the immediate increase in work load. The limited availability of staff resources was the most apparent area of improvement. Conclusion Under certain conditions, community pharmacies are feasible as a setting for conducting patient surveys in drug utilization research, and dispensing pharmacists suitable for conducting them. When regular dispensing staff perform the survey interviews as a part of the drug dispensing process, additional resources to manage the immediate increase in work load have to be considered. Otherwise, data quality may be compromised.
Literature
1.
go back to reference Carvajal A, Sáinz M, Velasco V, García Ortega P, Treceño C, Martín Arias LH, et al. Emergency contraceptive pill safety profile: comparison of the results of a follow-up study to those coming from spontaneous reporting. Pharmacoepidemiol Drug Saf. 2015;24(1):93–7.CrossRefPubMed Carvajal A, Sáinz M, Velasco V, García Ortega P, Treceño C, Martín Arias LH, et al. Emergency contraceptive pill safety profile: comparison of the results of a follow-up study to those coming from spontaneous reporting. Pharmacoepidemiol Drug Saf. 2015;24(1):93–7.CrossRefPubMed
2.
go back to reference Strandell B, Norgren-Holst E, Tran N, Jakobsen HB, Chen S. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold. Int J Clin Pharmacol Ther. 2009;47(12):744–51.CrossRefPubMed Strandell B, Norgren-Holst E, Tran N, Jakobsen HB, Chen S. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold. Int J Clin Pharmacol Ther. 2009;47(12):744–51.CrossRefPubMed
3.
go back to reference Brusa P, Allais G, Bussone G, Rolando S, Giaccone M, Aguggia M, et al. Migraine attacks in the pharmacy: a survey in Piedmont, Italy. Neurol Sci. 2014;35(Suppl 1):5–9.CrossRefPubMed Brusa P, Allais G, Bussone G, Rolando S, Giaccone M, Aguggia M, et al. Migraine attacks in the pharmacy: a survey in Piedmont, Italy. Neurol Sci. 2014;35(Suppl 1):5–9.CrossRefPubMed
4.
go back to reference Carvajal A, Arias LH, Vega E, Sanchez JA, Rodriguez IM, Ortega PG, et al. Gastroprotection during the administration of non-steroidal antiinflammatory drugs: a drug utilization-study. Eur J Clin Pharmacol. 2004;60(6):439–44.CrossRefPubMed Carvajal A, Arias LH, Vega E, Sanchez JA, Rodriguez IM, Ortega PG, et al. Gastroprotection during the administration of non-steroidal antiinflammatory drugs: a drug utilization-study. Eur J Clin Pharmacol. 2004;60(6):439–44.CrossRefPubMed
5.
go back to reference Mehuys E, Paemeleire K, Van Hees T, Christiaens T, Van Bortel LM, Van Tongelen I, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19(8):1093–9.CrossRefPubMed Mehuys E, Paemeleire K, Van Hees T, Christiaens T, Van Bortel LM, Van Tongelen I, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19(8):1093–9.CrossRefPubMed
6.
go back to reference Frisk P, Kälvemark-Sporrong S, Wettermark B. Selection bias in pharmacy-based patient surveys. Pharmacoepidemiol Drug Saf. 2014;23:128–39.CrossRefPubMed Frisk P, Kälvemark-Sporrong S, Wettermark B. Selection bias in pharmacy-based patient surveys. Pharmacoepidemiol Drug Saf. 2014;23:128–39.CrossRefPubMed
7.
go back to reference Medical Products Agency. Läkemedelsverkets föreskrifter om förordnande och utlämnande av läkemedel och teknisk sprit [Medical product agency’s directives on the prescribing and distribution of pharmaceuticals and laboratory alcohol]. LVFS. 2009;13:2009. Medical Products Agency. Läkemedelsverkets föreskrifter om förordnande och utlämnande av läkemedel och teknisk sprit [Medical product agency’s directives on the prescribing and distribution of pharmaceuticals and laboratory alcohol]. LVFS. 2009;13:2009.
8.
go back to reference Tolonen H, Ahonen S, Jentoft S, Kuulasmaa K, Heldal J. Differences in participation rates and lessons learned about recruitment of participants—the European Health Examination Survey Pilot Project. Scand J Publ Health. 2015;. doi:10.1177/1403494814565692. Tolonen H, Ahonen S, Jentoft S, Kuulasmaa K, Heldal J. Differences in participation rates and lessons learned about recruitment of participants—the European Health Examination Survey Pilot Project. Scand J Publ Health. 2015;. doi:10.​1177/​1403494814565692​.
9.
go back to reference Knudsen AK, Hotopf M, Skogen JC, Overland S, Mykletun A. The health status of status of nonparticipants in a population-based health study: the Hordaland Health Study. Am J Epidemiol. 2010;172(11):1306–14.CrossRefPubMed Knudsen AK, Hotopf M, Skogen JC, Overland S, Mykletun A. The health status of status of nonparticipants in a population-based health study: the Hordaland Health Study. Am J Epidemiol. 2010;172(11):1306–14.CrossRefPubMed
10.
go back to reference Nummela O, Sulander T, Helakorpi S, Haapola I, Uutela A, Heinonen H, et al. Register-based data indicated nonparticipation bias in a health study among aging people. J Clin Epidemiol. 2011;64(12):1418–25.CrossRefPubMed Nummela O, Sulander T, Helakorpi S, Haapola I, Uutela A, Heinonen H, et al. Register-based data indicated nonparticipation bias in a health study among aging people. J Clin Epidemiol. 2011;64(12):1418–25.CrossRefPubMed
11.
go back to reference Robson C. Real World Research. 3rd ed. Oxford: Blackwell Publishing; 2011. ISBN 978-1-4051-82409. Robson C. Real World Research. 3rd ed. Oxford: Blackwell Publishing; 2011. ISBN 978-1-4051-82409.
12.
go back to reference Sandelowski M. Focus on research methods: whatever happened to qualitative description? Res Nurs Health. 2000;23:334–40.CrossRefPubMed Sandelowski M. Focus on research methods: whatever happened to qualitative description? Res Nurs Health. 2000;23:334–40.CrossRefPubMed
13.
go back to reference Sandelowski M. What’s in a name? Qualitative description revisited. Res Nurs Health. 2010;33:77–84.PubMed Sandelowski M. What’s in a name? Qualitative description revisited. Res Nurs Health. 2010;33:77–84.PubMed
14.
go back to reference Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320(7227):114–6. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320(7227):114–6.
16.
go back to reference Bradburn N, Sudman S, Wansink B. Asking questions: the definitive guide to questionnaire design. San Francisco: Wiley; 2004. ISBN 0-7879-7088-3. Bradburn N, Sudman S, Wansink B. Asking questions: the definitive guide to questionnaire design. San Francisco: Wiley; 2004. ISBN 0-7879-7088-3.
17.
go back to reference Sporrong SK, Höglund AT, Hansson MG, Westerholm P, Arnetz B. “We are white coats whirling round”—moral distress in Swedish pharmacies. Pharm World Sci. 2005;27:223–9.CrossRefPubMed Sporrong SK, Höglund AT, Hansson MG, Westerholm P, Arnetz B. “We are white coats whirling round”—moral distress in Swedish pharmacies. Pharm World Sci. 2005;27:223–9.CrossRefPubMed
18.
go back to reference Shaheed CA, Maher CG, Williams KA, McLachlan AJ. Participation of pharmacists in clinical trial recruitment for low back pain. Int J Clin Pharm. 2014;36:986–94.CrossRefPubMed Shaheed CA, Maher CG, Williams KA, McLachlan AJ. Participation of pharmacists in clinical trial recruitment for low back pain. Int J Clin Pharm. 2014;36:986–94.CrossRefPubMed
19.
go back to reference Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, et al. Involving community pharmacists in pharmacy practice research: experiences of peer interviewing. Int J Clin Pharm. 2015;37(1):31–5.CrossRefPubMed Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, et al. Involving community pharmacists in pharmacy practice research: experiences of peer interviewing. Int J Clin Pharm. 2015;37(1):31–5.CrossRefPubMed
20.
go back to reference Gidman WK, Hassell K, Day J, Payne K. The impact of increasing workloads and role expansion on female community pharmacists in the United Kingdom. Res Social Adm Pharm. 2007;3(3):285–302.CrossRefPubMed Gidman WK, Hassell K, Day J, Payne K. The impact of increasing workloads and role expansion on female community pharmacists in the United Kingdom. Res Social Adm Pharm. 2007;3(3):285–302.CrossRefPubMed
21.
go back to reference Sleath B. Pharmacist–patient relationships: authoritarian, participatory, or default? Patient Educ Couns. 1996;28:253–63.CrossRefPubMed Sleath B. Pharmacist–patient relationships: authoritarian, participatory, or default? Patient Educ Couns. 1996;28:253–63.CrossRefPubMed
22.
go back to reference Tully MP, Beckman-Gyllenstrand A, Bernsten CB. Factors predicting poor counselling about prescription medicines in Swedish community pharmacies. Patient Educ Couns. 2011;83:3–6.CrossRefPubMed Tully MP, Beckman-Gyllenstrand A, Bernsten CB. Factors predicting poor counselling about prescription medicines in Swedish community pharmacies. Patient Educ Couns. 2011;83:3–6.CrossRefPubMed
23.
go back to reference Olsson E, Ingman P, Ahmed B, Kälvemark Sporrong S. Pharmacist–patient communication in Swedish community pharmacies. Res Social Adm Pharm. 2014;10(1):149–55.CrossRefPubMed Olsson E, Ingman P, Ahmed B, Kälvemark Sporrong S. Pharmacist–patient communication in Swedish community pharmacies. Res Social Adm Pharm. 2014;10(1):149–55.CrossRefPubMed
24.
go back to reference Kaae S, Nørgaard LS. How to engage experienced medicine users at the counter for a pharmacy-based asthma inhaler service. Int J Pharm Pract. 2012;20:99–106.CrossRefPubMed Kaae S, Nørgaard LS. How to engage experienced medicine users at the counter for a pharmacy-based asthma inhaler service. Int J Pharm Pract. 2012;20:99–106.CrossRefPubMed
25.
go back to reference Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender and patient question asking behaviour with the content of pharmacist-patient communication. Pharm Res. 1997;14:145–51.CrossRefPubMed Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender and patient question asking behaviour with the content of pharmacist-patient communication. Pharm Res. 1997;14:145–51.CrossRefPubMed
26.
go back to reference Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CSI, Airaksinen MSA. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Pract. 2005;13(2):149–56.CrossRef Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CSI, Airaksinen MSA. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Pract. 2005;13(2):149–56.CrossRef
27.
go back to reference Ax F, Brånstad JO, Westerlund T. Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther. 2010;35(4):439–51.PubMed Ax F, Brånstad JO, Westerlund T. Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther. 2010;35(4):439–51.PubMed
28.
go back to reference Cavaco AN, Romano JP. Exploring pharmacist-customer communication: the established blood pressure measurement episode. Pharm World Sci. 2010;32(5):601–9.CrossRefPubMed Cavaco AN, Romano JP. Exploring pharmacist-customer communication: the established blood pressure measurement episode. Pharm World Sci. 2010;32(5):601–9.CrossRefPubMed
29.
go back to reference Mott DA, Doucette WR, Pedersen CA, Schommer JC. Pharmacists’ attitudes toward worklife: results from a national survey of pharmacists. J Am Pharm Assoc. 2004;44:326–36.CrossRef Mott DA, Doucette WR, Pedersen CA, Schommer JC. Pharmacists’ attitudes toward worklife: results from a national survey of pharmacists. J Am Pharm Assoc. 2004;44:326–36.CrossRef
30.
go back to reference Bertakis KD. The influence of gender on the doctor-patient interaction. Patient Educ Couns. 2009;76(3):356–60.CrossRefPubMed Bertakis KD. The influence of gender on the doctor-patient interaction. Patient Educ Couns. 2009;76(3):356–60.CrossRefPubMed
31.
go back to reference Schieber AC, Delpierre C, Lepage B, Afrite A, Pascal J, Cases C, INTERMEDE Group, et al. Do gender differences affect the doctor–patient interaction during consultations in general practice? Results from the INTERMEDE study. Fam Pract. 2014;31(6):706–13.CrossRefPubMed Schieber AC, Delpierre C, Lepage B, Afrite A, Pascal J, Cases C, INTERMEDE Group, et al. Do gender differences affect the doctor–patient interaction during consultations in general practice? Results from the INTERMEDE study. Fam Pract. 2014;31(6):706–13.CrossRefPubMed
32.
go back to reference Apotekarsocieteten. Svensk farmaceutisk matrikel [Swedish pharmaceutical directory]. 113th ed. Stockholm: Apotekarsocieteten, Läkemedelsakademin i Stockholm AB; 2009. Apotekarsocieteten. Svensk farmaceutisk matrikel [Swedish pharmaceutical directory]. 113th ed. Stockholm: Apotekarsocieteten, Läkemedelsakademin i Stockholm AB; 2009.
Metadata
Title
Exploring community pharmacists’ experiences of surveying patients for drug utilization research purposes
Authors
Pia Frisk
Ulrika Bergman
Sofia Kälvemark-Sporrong
Publication date
01-06-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0088-1

Other articles of this Issue 3/2015

International Journal of Clinical Pharmacy 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine